JP2007506703A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506703A5 JP2007506703A5 JP2006527374A JP2006527374A JP2007506703A5 JP 2007506703 A5 JP2007506703 A5 JP 2007506703A5 JP 2006527374 A JP2006527374 A JP 2006527374A JP 2006527374 A JP2006527374 A JP 2006527374A JP 2007506703 A5 JP2007506703 A5 JP 2007506703A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- quinolinecarboxamide
- hydrogen
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322722.0A GB0322722D0 (en) | 2003-09-27 | 2003-09-27 | Compounds |
| PCT/EP2004/010844 WO2005030212A1 (en) | 2003-09-27 | 2004-09-23 | 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007506703A JP2007506703A (ja) | 2007-03-22 |
| JP2007506703A5 true JP2007506703A5 (OSRAM) | 2007-09-20 |
Family
ID=29287002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006527374A Pending JP2007506703A (ja) | 2003-09-27 | 2004-09-23 | Ｐｄｅ４阻害剤としての４−アミノキノリン−３−カルボキサミド誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20080096884A1 (OSRAM) |
| EP (1) | EP1673086B1 (OSRAM) |
| JP (1) | JP2007506703A (OSRAM) |
| AR (1) | AR045824A1 (OSRAM) |
| AT (1) | ATE384530T1 (OSRAM) |
| DE (1) | DE602004011548T2 (OSRAM) |
| ES (1) | ES2298806T3 (OSRAM) |
| GB (1) | GB0322722D0 (OSRAM) |
| TW (1) | TW200526584A (OSRAM) |
| WO (1) | WO2005030212A1 (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI328009B (en) * | 2003-05-21 | 2010-08-01 | Glaxo Group Ltd | Quinoline derivatives as phosphodiesterase inhibitors |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| GB0605462D0 (en) * | 2006-03-17 | 2006-04-26 | Glaxo Group Ltd | Novel compounds |
| WO2008052734A1 (en) | 2006-10-30 | 2008-05-08 | Novartis Ag | Heterocyclic compounds as antiinflammatory agents |
| JP5584138B2 (ja) | 2008-01-11 | 2014-09-03 | ノバルティス アーゲー | キナーゼ阻害剤としてのピリミジン類 |
| EP2379076B1 (en) * | 2008-12-23 | 2014-11-12 | The Trustees of Columbia University in the City of New York | Phosphodiesterase inhibitors and uses thereof |
| WO2010097248A1 (en) | 2009-01-13 | 2010-09-02 | Glaxo Group Limited | Pyrimidinecarboxamide derivatives as inhibitors of syk kinase |
| US8367829B2 (en) | 2010-05-10 | 2013-02-05 | Gilead Sciences, Inc. | Bi-functional pyrazolopyridine compounds |
| US8394829B2 (en) | 2010-05-10 | 2013-03-12 | Gilead Sciences, Inc. | Bi-functional quinoline analogs |
| UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| CA2828219A1 (en) | 2011-02-25 | 2012-08-30 | Irm Llc | Pyrazolo [1,5-a] pyridines as trk inhibitors |
| BR112015019276A2 (pt) | 2013-02-19 | 2017-07-18 | Pfizer | compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios |
| US10131669B2 (en) | 2014-07-24 | 2018-11-20 | Pfizer Inc. | Pyrazolopyrimidine compounds |
| EA031201B1 (ru) | 2014-08-06 | 2018-11-30 | Пфайзер Инк. | Соединения имидазопиридазина |
| MA41140A (fr) | 2014-12-12 | 2017-10-17 | Cancer Research Tech Ltd | Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg |
| MA41179A (fr) | 2014-12-19 | 2017-10-24 | Cancer Research Tech Ltd | Composés inhibiteurs de parg |
| BR112018006873A2 (pt) | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
| TW202345809A (zh) | 2022-03-23 | 2023-12-01 | 美商愛德亞生物科學公司 | 作為parg抑制劑之經哌取代的吲唑化合物 |
| TW202430172A (zh) * | 2023-01-17 | 2024-08-01 | 大陸商瑞石生物醫藥有限公司 | Ｐｄｅ４抑制劑、其製備方法及其在醫藥上的應用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR920701162A (ko) * | 1990-03-28 | 1992-08-11 | 오츠카 아끼히코 | 퀴놀린 유도체, 당해 유도체를 함유하는 항궤양제 및 당해 유도체의 제조방법 |
| AU722662B2 (en) * | 1996-05-20 | 2000-08-10 | Darwin Discovery Limited | Quinoline sulfonamides as TNF inhibitors and as PDE-IV inhibitors |
| ATE303993T1 (de) * | 1997-12-22 | 2005-09-15 | Pharmacia & Upjohn Co Llc | 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe |
| US6576644B2 (en) * | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
| SE0101675D0 (sv) * | 2001-05-11 | 2001-05-11 | Astrazeneca Ab | Novel composition |
| JO2311B1 (en) * | 2001-08-29 | 2005-09-12 | ميرك فروست كندا ليمتد | Alkyl inhibitors Ariel phosphodiesterase-4 |
-
2003
- 2003-09-27 GB GBGB0322722.0A patent/GB0322722D0/en not_active Ceased
-
2004
- 2004-09-23 ES ES04765656T patent/ES2298806T3/es not_active Expired - Lifetime
- 2004-09-23 DE DE602004011548T patent/DE602004011548T2/de not_active Expired - Fee Related
- 2004-09-23 WO PCT/EP2004/010844 patent/WO2005030212A1/en not_active Ceased
- 2004-09-23 US US10/572,914 patent/US20080096884A1/en not_active Abandoned
- 2004-09-23 JP JP2006527374A patent/JP2007506703A/ja active Pending
- 2004-09-23 EP EP04765656A patent/EP1673086B1/en not_active Expired - Lifetime
- 2004-09-23 AT AT04765656T patent/ATE384530T1/de not_active IP Right Cessation
- 2004-09-24 TW TW093129113A patent/TW200526584A/zh unknown
- 2004-09-24 AR ARP040103472A patent/AR045824A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007506703A5 (OSRAM) | ||
| JP2007501264A5 (OSRAM) | ||
| CA2526228A1 (en) | Quinoline derivatives as phosphodiesterase inhibitors | |
| JP2007501831A5 (OSRAM) | ||
| ES2316575T3 (es) | Derivado de fenilpiridincarbonilpiperazina. | |
| JP2005533803A5 (OSRAM) | ||
| JP4216196B2 (ja) | Ｎｐｙアンタゴニストとしてのキノリン誘導体 | |
| JP2007529486A5 (OSRAM) | ||
| JP2008517926A5 (OSRAM) | ||
| JP2004531473A5 (OSRAM) | ||
| JP2004504301A5 (OSRAM) | ||
| JP2020512343A5 (OSRAM) | ||
| JP2005501120A5 (OSRAM) | ||
| CA2730471A1 (en) | Piperazine derivatives used as cav2.2 calcium channel modulators | |
| CA2474738A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| RU2003102612A (ru) | N-окиси в качестве пролекарств производных 4-фенилпиридина, являющихся натагонистами рецептора nk-1 | |
| JP2005535586A5 (OSRAM) | ||
| JP2010510999A5 (OSRAM) | ||
| JP2011515462A5 (OSRAM) | ||
| CA2585053A1 (en) | Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors | |
| JP2006502112A5 (OSRAM) | ||
| JP2019505595A5 (OSRAM) | ||
| JP2005509622A5 (OSRAM) | ||
| CA2681809A1 (en) | Imidazolidinone derivatives | |
| JP2012513398A5 (OSRAM) |